CCCheong-Hee Chang

Cheong-Hee Chang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Cheong-Hee Chang has a total of 12 co-authors. Here are the top co-authors by number of shared publications:

  • Wei Li

    Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202

    2 shared publications
  • Dipak R. Patel

    Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109, USA

    1 shared publication
  • Gaio Hangoc

    Department of Microbiology and Immunology and Walther Oncology Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA

    1 shared publication
  • Jae-Seung Park

    Department of Microbiology and Immunology and Walther Oncology Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA

    1 shared publication
  • Kevin M. Nickerson

    Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

    1 shared publication
  • M. Hanief Sofi

    Department of Microbiology and Immunology and Walther Oncology Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA

    1 shared publication

Latest Publications

  • Open Access

    Interleukin (IL)-4 inhibits IL-10 to promote IL-12 production by dendritic cells

    by Yongxue Yao, Wei Li, Mark H. Kaplan, Cheong-Hee Chang

    Interleukin (IL)-4 is known to be the most potent cytokine that can initiate Th2 cell differentiation. Paradoxically, IL-4 instructs dendritic cells (DCs) to promote Th1 cell differentiation. We investigated the mechanisms by which IL-4 directs CD4 T cells toward the Th1 cell lineage. Our study demonstrates that the IL-4–mediated induction of Th1 cell differentiation requires IL-10 production by DCs. IL-4 treatment of DCs in the presence of lipopolysaccharide or CpG resulted in decreased production of IL-10, which was accompanied by enhanced IL-12 production. In IL-10–deficient DCs, the level of IL-12 was greatly elevated and, more importantly, the ability of IL-4 to up-regulate IL-12 was abrogated. Interestingly, IL-4 inhibited IL-10 production by DCs but not by B cells. The down-regulation of IL-10 gene expression by IL-4 depended on Stat6 and was at least partly caused by decreased histone acetylation of the IL-10 promoter. These data indicate that IL-4 plays a key role in inducing Th1 cell differentiation by instructing DCs to produce less IL-10.


  • Constitutive expression of CIITA directs CD4 T cells to produce Th2 cytokines in the thymus

    by Dipak R. Patel, Wei Li, Jae-Seung Park, M. Hanief Sofi, Tania S. Gourley, Gaio Hangoc, Mark H. Kaplan, Cheong-Hee Chang


  • Open Access

    Phosphorylation of class II transactivator regulates its interaction ability and transactivation function

    by Tyler J. Sisk, Kevin Nickerson, Roland P. S. Kwok, Cheong‐Hee Chang

    The MHC class II transactivator (CIITA) plays a central role in adaptive immune responses by controlling the expression of MHC class II genes. CIITA binds DNA‐binding proteins and co‐activator proteins to form an enhanceosome complex necessary for MHC class II gene expression. Here we demonstrate that CIITA interactions depend upon the phosphorylation status of CIITA. Hyper‐phosphorylated CIITA interacts with co‐activator p300, RFX5 and CIITA itself, which in turn results in induction of MHC class II promoter activity. Moreover, the C‐terminal region of CIITA containing leucine‐rich repeats (LRR) is a regulatory domain for CIITA self‐association and LRR binding to CIITA is negatively regulated by phosphorylation. cAMP‐dependent protein kinase (PKA) phosphorylates CIITA, and serine residues residing in a region between the proline/serine/threonine‐rich domain and the GTP‐binding domain are phosphorylated by PKA in vitro. The maximum transactivation potential of CIITA requires PKA phosphorylation as demonstrated by reduced transactivation activities of the mutant bearing substitutions of serine residues at the PKA site.